Literature DB >> 9033282

Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma.

Y Yang1, J Hao, X Liu, B Dalkin, R B Nagle.   

Abstract

The expression of cytokeratin (CK) mRNA for CK5, -8, -14, -16, and -19 was investigated in normal prostate, prostatic intraepithelial neoplasia (PIN) lesions, and invasive carcinoma using in situ hybridization. Protein localization was carried out in adjacent sections using immunohistochemistry and correlated with mRNA expression. Snap-frozen human prostate samples including 22 examples of normal glands, 20 cases of PIN lesions, and 12 cases of invasive carcinoma were examined. CK5 and -14 mRNA and protein were prominently expressed only in the basal cells of normal glands and PIN lesions. CK14 mRNA was absent in the luminal cells of the most of the PIN lesions but was seen at a low level in some PIN lesions. CK14 protein was not detected in any PIN lesion, suggesting that, if the cell that makes up the PIN lesions is derived from a basal cell, CK14 translation is depressed although a low level of CK14 mRNA may persist. CK8 mRNA and protein were constitutively expressed in all epithelia of normal and abnormal prostate tissues. CK19 mRNA and protein were persistently expressed in both basal and luminal cells of the tubular portion of normal glands as well as PIN lesions, but were expressed heterogeneously in both basal and luminal cells of normal alveoli. CK16 mRNA was expressed in a similar pattern as CK19, but CK16 protein was not detected either in normal or in abnormal prostate tissues. In conclusion, the expression of CK19 in PIN lesions is similar to its tubular expression and would support an origin of PIN lesions from this structure rather than the alveolar portion of the glands. The similar cytokeratin expression between PIN lesions and invasive carcinoma further supports the concept that PIN is a precursor lesion of invasive carcinoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9033282      PMCID: PMC1858264     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Cytokeratin characterization of human prostatic carcinoma and its derived cell lines.

Authors:  R B Nagle; F R Ahmann; K M McDaniel; M L Paquin; V A Clark; A Celniker
Journal:  Cancer Res       Date:  1987-01-01       Impact factor: 12.701

2.  Three tightly linked genes encoding human type I keratins: conservation of sequence in the 5'-untranslated leader and 5'-upstream regions of coexpressed keratin genes.

Authors:  A RayChaudhury; D Marchuk; M Lindhurst; E Fuchs
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

3.  Complete sequence of a gene encoding a human type I keratin: sequences homologous to enhancer elements in the regulatory region of the gene.

Authors:  D Marchuk; S McCrohon; E Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

4.  Keratin immunoreactivity in the benign and neoplastic human prostate.

Authors:  M K Brawer; D M Peehl; T A Stamey; D G Bostwick
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

5.  Intraductal dysplasia: a premalignant lesion of the prostate.

Authors:  J E McNeal; D G Bostwick
Journal:  Hum Pathol       Date:  1986-01       Impact factor: 3.466

6.  Basal cell proliferation in benign prostatic hyperplasia.

Authors:  G B Dermer
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

7.  Immunohistochemistry of the cytoskeleton of human prostatic epithelium. Evidence for disturbed organization in neoplasia.

Authors:  D M Purnell; B M Heatfield; R L Anthony; B F Trump
Journal:  Am J Pathol       Date:  1987-02       Impact factor: 4.307

8.  Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue.

Authors:  L N Turkeri; W A Sakr; S M Wykes; D J Grignon; J E Pontes; J A Macoska
Journal:  Prostate       Date:  1994-10       Impact factor: 4.104

9.  Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes.

Authors:  R A Weiss; R Eichner; T T Sun
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

10.  Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression.

Authors:  J P Molès; J T Schiller; A Tesniere; I M Leigh; J J Guilhou; N Basset-Séguin
Journal:  J Cell Sci       Date:  1994-02       Impact factor: 5.285

View more
  11 in total

1.  Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.

Authors:  A M De Marzo; V L Marchi; J I Epstein; W G Nelson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  In stage II/III lymph node-positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumour is an indicator of better survival.

Authors:  Serena Bonin; Danae Pracella; Renzo Barbazza; Sandro Sulfaro; Giorgio Stanta
Journal:  Virchows Arch       Date:  2015-02-28       Impact factor: 4.064

3.  Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.

Authors:  R E Reiter; Z Gu; T Watabe; G Thomas; K Szigeti; E Davis; M Wahl; S Nisitani; J Yamashiro; M M Le Beau; M Loda; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

4.  Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.

Authors:  A M De Marzo; A K Meeker; J I Epstein; D S Coffey
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

5.  Differential expression of cytokeratin after orthotopic implantation of newly established human tongue cancer cell lines of defined metastatic ability.

Authors:  M Morifuji; S Taniguchi; H Sakai; Y Nakabeppu; M Ohishi
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

6.  PC3 is a cell line characteristic of prostatic small cell carcinoma.

Authors:  Sheng Tai; Yin Sun; Jill M Squires; Hong Zhang; William K Oh; Chao-Zhao Liang; Jiaoti Huang
Journal:  Prostate       Date:  2011-03-22       Impact factor: 4.104

7.  Transcriptomes of human prostate cells.

Authors:  Asa J Oudes; Dave S Campbell; Carrie M Sorensen; Laura S Walashek; Lawrence D True; Alvin Y Liu
Journal:  BMC Genomics       Date:  2006-04-25       Impact factor: 3.969

8.  The Effects of Long-Term Immunosuppressive Therapies on the Structure of the Rat Prostate.

Authors:  Marta Grabowska; Maria Laszczyńska; Karolina Kędzierska-Kapuza; Andrzej Kram; Kamil Gill; Małgorzata Piasecka
Journal:  Int J Environ Res Public Health       Date:  2020-06-26       Impact factor: 3.390

9.  Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer.

Authors:  W Nathaniel Brennen; Yezi Zhu; Ilsa M Coleman; Susan L Dalrymple; Lizamma Antony; Radhika A Patel; Brian Hanratty; Roshan Chikarmane; Alan K Meeker; S Lilly Zheng; Jody E Hooper; Jun Luo; Angelo M De Marzo; Eva Corey; Jianfeng Xu; Srinivasan Yegnasubramanian; Michael C Haffner; Peter S Nelson; William G Nelson; William B Isaacs; John T Isaacs
Journal:  JCI Insight       Date:  2021-04-22

10.  Mouse prostate epithelial luminal cells lineage originate in the basal layer where the primitive stem/early progenitor cells reside: implications for identifying prostate cancer stem cells.

Authors:  Jianjun Zhou; Lionel Feigenbaum; Carole Yee; Hongbin Song; Clayton Yates
Journal:  Biomed Res Int       Date:  2013-06-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.